MET and cancer: A number of studies have reported that cancer-associated RTKs, such as EGFRs, fibroblast growth factor receptor-2 (FGFR2), EphA2, and hepatocyte growth factor receptor (HGFR), all carry truncated O-glycans in their extracellular domains [24,28,30,38].